Edition:
India

Insider Trading: Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

1.86USD
11 Dec 2019
Change (% chg)

-- (--)
Prev Close
$1.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,115
52-wk High
$5.93
52-wk Low
$1.52

All Insider Trades
Trading Date Name Title Type Shares Traded Price
30 Nov 2019

Garg (Vipin K. Ph.D.)

Chief Executive Officer Sell 23,976 $1.82
5 Sep 2019

Garg (Vipin K. Ph.D.)

Chief Executive Officer Buy 20,000 $2.10
30 Nov 2018

Garg (Vipin K. Ph.D.)

Chief Executive Officer Buy 322,907 $0.00
9 Oct 2018

Pisano (Wayne)

Director Buy 2,000 $4.59
12 Sep 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 2,069,993 $0.00
11 Jul 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 663,346 $0.00
15 Jun 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 14,449 $0.00
13 Jun 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 720,878 $0.00
25 May 2018

Enright (William)

Chief Executive Officer Buy 1,300 $0.51
21 May 2018

Roberts M Stephen

Officer Buy 55,120 $0.08
16 May 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 767,728 $0.00
15 May 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 274,703 $0.00
16 Apr 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 217,159 $0.00
16 Apr 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 482,907 $0.00
15 Mar 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 261,969 $0.00
15 Feb 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 5,977 $0.00
15 Feb 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 67,925 $0.00
15 Feb 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 4,483 $0.00
15 Feb 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 4,483 $0.00
13 Feb 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 17,789 $0.00
13 Feb 2018

Novartis Bioventures Ltd

Beneficial Owner of More than 10% Class Buy 269,527 $0.00
13 Feb 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 23,719 $0.00
13 Feb 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 17,789 $0.00
17 Jan 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 15,541 $0.00
17 Jan 2018

Truffle Capital SAS

Beneficial Owner of More than 10% Class Buy 11,655 $0.00

Institutional Holders

% Shares Owned: 7.29%
# of Holders: 32
Total Shares Held: 1,118,184
3 Mo. Net Change: 81,759
# New Positions: 12
# Closed Positions: 3
# Increased Positions: 16
# Reduced Positions: 11
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

Mitchel Sayare

71 2018 Chairman of the Board

Vipin Garg

62 2018 President, Chief Executive Officer, Director

William Brown

37 2019 Chief Financial Officer, Principal Accounting Officer

M. Scot Roberts

60 2017 Chief Scientific Officer

David Drutz

81 2018 Independent Director

John Gill

67 2017 Director

Philip Hodges

51 2017 Independent Director

Klaus Schafer

69 2017 Independent Director

Wayne Pisano

64 2018 Independent Director

Ashley Robinson

2017 IR Contact Officer